Scarica l'app Stockscreener
2.57
0.39%
0.010
Dopo l'orario di chiusura:
2.57
Precedente Chiudi:
$2.56
Aprire:
$2.57
Volume 24 ore:
138.30K
Relative Volume:
0.57
Capitalizzazione di mercato:
$115.15M
Reddito:
$8,000
Utile/perdita netta:
$-32.15M
Rapporto P/E:
-2.9677
EPS:
-0.866
Flusso di cassa netto:
$-26.37M
1 W Prestazione:
-2.28%
1M Prestazione:
-11.99%
6M Prestazione:
-41.46%
1 anno Prestazione:
+1.18%
Intervallo 1D:
$2.48
$2.61
Intervallo di 1 settimana:
$2.29
$2.70
Portata 52W:
$1.9875
$8.535
Genelux Corp Stock (GNLX) Company Profile
Nome
Genelux Corp
Settore
Industria
Telefono
805-267-9889
Indirizzo
2625 TOWNSGATE ROAD, SUITE 230, WESTLAKE VILLAGE
Compare GNLX vs VRTX, REGN, ARGX, ALNY, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GNLX
Genelux Corp
|
2.57 | 115.15M | 8,000 | -32.15M | -26.37M | -0.866 |
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Genelux Corp Stock (GNLX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-21 | Iniziato | Lake Street | Buy |
| 2024-10-29 | Iniziato | Guggenheim | Buy |
| 2024-08-28 | Iniziato | ROTH MKM | Buy |
| 2023-11-27 | Iniziato | H.C. Wainwright | Buy |
| 2023-09-12 | Iniziato | Maxim Group | Buy |
| 2023-02-15 | Iniziato | The Benchmark Company | Speculative Buy |
Mostra tutto
Genelux Corp Borsa (GNLX) Ultime notizie
GNLX SEC FilingsGenelux Corp 10-K, 10-Q, 8-K Forms - Stock Titan
GNLX Technical Analysis & Stock Price Forecast - Intellectia AI
Analyst Calls: Can Genelux Corporation outperform in the next rally2026 Market Outlook & AI Driven Price Predictions - baoquankhu1.vn
GNLX PE Ratio & Valuation, Is GNLX Overvalued - Intellectia AI
Cappello, Genelux CTO, sells $2192 in GNLX stock By Investing.com - au.investing.com
Genelux head of regulatory sells $1.4k in shares By Investing.com - Investing.com Australia
Yu Yong, Genelux SVP, sells $2192 in GNLX stock By Investing.com - in.investing.com
Genelux CEO Zindrick sells $8668 in shares By Investing.com - Investing.com South Africa
Genelux head of regulatory sells $1.4k in shares - investing.com
Yu Yong, Genelux SVP, sells $2192 in GNLX stock - Investing.com
Genelux CEO Zindrick sells $8668 in shares - Investing.com
Genelux (GNLX) Head of Regulatory sells 585 shares to cover RSU taxes - Stock Titan
[Form 4] GENELUX Corp Insider Trading Activity - Stock Titan
Genelux (NASDAQ: GNLX) SVP sells 906 shares to cover RSU taxes - Stock Titan
Genelux (GNLX) CEO sells shares to cover RSU tax obligations - Stock Titan
AI Stocks: Is Genelux Corporation showing insider buyingShort Setup & Technical Pattern Alert System - baoquankhu1.vn
FY2029 Earnings Estimate for Genelux Issued By HC Wainwright - MarketBeat
Genelux (NASDAQ:GNLX) Upgraded by Wall Street Zen to "Hold" Rating - MarketBeat
Genelux (NASDAQ:GNLX) Upgraded by Wall Street Zen to “Hold” Rating - Defense World
Genelux (NASDAQ:GNLX) Price Target Cut to $20.00 by Analysts at Benchmark - MarketBeat
Genelux: Advancing Olvi-Vec Pivotal Program and Manufacturing Readiness Underpin Buy Rating and Long-Term Value Upside - TipRanks
Genelux Corp 2024 Annual Report: Oncolytic Virus Pipeline, Olvi-Vec Clinical Trials, Strategy, Risks, and Competitive Landscape 66686970719293 - minichart.com.sg
Gap Down: Can Genelux Corporation be recession proof2026 Fundamental Recap & Reliable Entry Point Trade Alerts - baoquankhu1.vn
Genelux (NASDAQ: GNLX) launches $100M at-the-market program with TD Cowen - Stock Titan
Genelux Establishes $100 Million At-The-Market Equity Program - TipRanks
Genelux Corp reports results for the quarter ended December 31Earnings Summary - TradingView
Genelux Establishes $100 Million ATM Equity Program With TD Cowen - TradingView
Genelux (NASDAQ: GNLX) launches $100M at-the-market stock plan - stocktitan.net
Genelux Corporation Announces Phase 3 Trial Data Timeline and Interim Results for Olvi-Vec in Ovarian and Lung Cancer, Alongside Leadership Appointment - Quiver Quantitative
[10-K] GENELUX Corp Files Annual Report | GNLX SEC FilingForm 10-K - Stock Titan
GENELUX 2025 10-K: Revenue $0.01M, Net Loss $32.1M - tradingview.com
Cancer drug readout nears as Genelux says cash lasts into 2027 - Stock Titan
Aug Analyst Calls: What is the long term forecast for Genelux Corporation stockMarket Trend Review & Free Verified High Yield Trade Plans - baoquankhu1.vn
Genelux Corp. (GNLX) Gets a Buy from Maxim Group - The Globe and Mail
Genelux Corp expected to post a loss of 22 cents a shareEarnings Preview - TradingView
Insider Sell: John Thomas Sells 10,000 Shares of Genelux Corp (G - GuruFocus
Insider Selling: Genelux (NASDAQ:GNLX) Director Sells 10,000 Shares of Stock - MarketBeat
[144] GENELUX Corp SEC Filing - Stock Titan
GNLX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
GNLX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Can Genelux Corporation outperform in the next rallyJuly 2025 Selloffs & Smart Allocation Stock Reports - baoquankhu1.vn
Genelux Corporation to Participate in Upcoming Conferences - Yahoo Finance
8.2% Genelux (NASDAQ: GNLX) stake disclosed by holder Aladar Szalay - Stock Titan
Will Genelux Corporation stock continue dividend increasesMarket Activity Report & Safe Capital Growth Tips - mfd.ru
Genelux Updates Corporate Presentation for Investors and Stakeholders - The Globe and Mail
US Stocks Recap: Is Outlook Therapeutics Inc stock good for income investorsM&A Rumor & Safe Capital Growth Plans - baoquankhu1.vn
Genelux appoints Jason Litten as CMO - MSN
Brokers Offer Predictions for Genelux Q1 Earnings - Defense World
Aug Sectors: Will Genelux Corporation benefit from AI trendsExit Point & High Yield Stock Recommendations - baoquankhu1.vn
Aug Momentum: Will Genelux Corporation benefit from AI trendsRate Hike & Smart Money Movement Tracker - baoquankhu1.vn
Genelux Corp Azioni (GNLX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):